Norfolk and Waveney ICB select MEDITECH to supply new Electronic Patient Records

Partnerships
Bicycle Health, Albertsons partner to expand access to OUD treatment
Bicycle Health is partnering with Albertsons for buprenorphine treatment for opioid use disorder. Patients can receive monthly injections at Albertsons pharmacies in 17 states. Read More>>

Deal
Norfolk and Waveney ICB select MEDITECH to supply new EPR
The Norfolk and Waveney Acute Hospital Collaborative has selected MEDITECH as the supplier for their new Electronic Patient Record system to enhance care quality. Read More>>

Centre Setup and Expansion
Monument Health breaks ground on Spearfish Hospital expansion
Monument Health has initiated a three-year expansion project for Spearfish Hospital to expand the hospital’s capacity and add operating rooms and intensive care unit rooms. Read More>>

Merger and Acquisition
Fortis Healthcare acquires Medeor Hospital Manesar for $27.1 Million
Fortis Healthcare has acquired Medeor Hospital Manesar in Haryana, India to expand its healthcare portfolio with a 350-bed multi-specialty hospital. Read More>>

Layoff
Biofourmis CEO Steps Down a Month After Global Layoffs
The company’s co-founder Kuldeep Singh Rajput stepped down as its CEO just one month after the company laid off 120 employees worldwide, 48 of whom were in the U.S. Read More>>

Partnership
CK Birla Hospital partners with Intuitive to adopt robotic-assisted surgery
The partnership will introduce the da Vinci robotic-assisted surgical system, enhancing surgical precision and patient outcomes, and will also include training for senior surgeons. Read More>>

Deal
Masimo and Franciscan Missionaries Sign Multi-year, System-wide Monitoring Agreement
The companies have signed the agreement for Masimo’s monitoring technologies, including pulse oximetry and remote monitoring solutions, across FMOLHS’s hospital system. Read More>>

Merger and Acquisition
Globus Medical Completes Merger with NuVasive
Globus Medical has finalized its merger with NuVasive, creating a prominent musculoskeletal healthcare provider. This merger offers comprehensive solutions and expands global reach. Read More>>

Centre Setup and Expansion
Medline adapts to accommodate the increase in orders from ASCs
Medline invests $75 million in a new distribution center in St. Peters, Missouri, to meet growing demand from healthcare institutions, including ASCs. Read More>>

Layoff
Johnson & Johnson wants to shutter Leiden vaccine lab and cut jobs
Janssen plans to close its vaccine division as part of J&J’s strategic shift towards prioritizing other treatment methods. The move may impact around 25% of its 2,500 employees. Read More>>

Partnership
Twist Bioscience, Ono Pharmaceutical Partner for Autoimmune Diseases Drug Discovery
The companies will focus on discovering antibodies for autoimmune diseases. Ono will handle product development, and Twist will receive research fees and royalties. Read More>>

Centre Setup and Expansion
Zoetis inaugurates new R&D building in North Carolina
The 78,000-square-foot R&D center in Durham houses labs for biodevice engineering, diagnostics engineering, and biodevice science. Read More>>

Executive Movement
Jaydeep Shah joins Sun Pharma as CMO of Consumer Health Business
Jaydeep Shah previously served as the Vice President and Chief Marketing Officer of Sebamed India, where he contributed to significant business growth. Read More>>

Merger and Acquisition
Amgen to acquire Horizon Therapeutics for $27.8 billion
This merger addresses antitrust concerns and highlights the need for government approval for new products related to rare diseases. Read More>>

Product Launch
Lupin Gets Tentative Approval From USFDA For HIV & Hepatitis Drugs
Lupin has gained tentative approval from the USFDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets, used to treat HIV/AIDS and chronic hepatitis B. Read More>>

• Strong R&D Capabilities: Otsuka Pharmaceutical has a reputation for robust research and development capabilities, allowing the company to innovate and develop new pharmaceutical products. 
• Diverse Product Portfolio: The company has a wide range of products across various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, and oncology, which helps diversify revenue streams. 
• Global Presence: Otsuka Pharmaceutical operates in multiple countries worldwide, providing access to diverse markets and reducing dependence on any single market.

Weaknesses:

• Dependence On Key Products: Otsuka Pharmaceutical relies heavily on a few key products for a significant portion of its revenue, exposing the company to risks such as patent expirations or generic competition. 
• Limited Geographic Presence in Some Markets: While Otsuka Pharmaceutical has a global presence, market penetration in certain regions may be limited compared to competitors, potentially impacting growth opportunities. 
• Relatively Small Size: Compared to some of its larger competitors in the pharmaceutical industry, Otsuka Pharmaceutical is relatively smaller in size, which may limit resources for aggressive expansion and marketing activities.

Key Funding Alert

GSK invests $269 Million-plus in vaccine manufacturing as Shingrix surges
GSK is investing in a new manufacturing facility at its Wavre campus in Belgium, expected to be operational by 2027. The investment aims to enhance manufacturing efficiency and reduce environmental impact. Read More>>

Startup Spotlight

Company – OXOS Medical
Total Funding – USD 41.69 Mn
About: OXOS offers a suite of connected radiographic instruments that allow users to capture radiographic data with minimal training, integrating directly into OXOS’s telehealth delivery platform. It enables anyone anywhere to access radiologic diagnostics at the point of care. Read More>>

Here’s what’s new on our Sales Intelligence Platform
Introducing personalized Braindesk landing page

• Experience the new personalized BrainDesk landing page
• Now you can easily filter courses in Reskilling based on difficulty levels to prepare a personalized learning plan
• Introducing a breakdown of IT spending by category, along with a forecast in Financials, enabling you to understand target account expenditure